These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 25473078)

  • 1. A Proton Pump Inhibitor's Effect on Bone Metabolism Mediated by Osteoclast Action in Old Age: A Prospective Randomized Study.
    Jo Y; Park E; Ahn SB; Jo YK; Son B; Kim SH; Park YS; Kim HJ
    Gut Liver; 2015 Sep; 9(5):607-14. PubMed ID: 25473078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioavailability and tolerability of combination treatment with revaprazan 200 mg + itopride 150 mg: a randomized crossover study in healthy male Korean volunteers.
    Choi HY; Noh YH; Jin SJ; Kim YH; Kim MJ; Sung H; Jang SB; Lee SJ; Bae KS; Lim HS
    Clin Ther; 2012 Sep; 34(9):1999-2010. PubMed ID: 22858177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Revaprazan prevented indomethacin-induced intestinal damages by enhancing tight junction related mechanisms.
    Han YM; Park JM; Her S; Kim MS; Park YJ; Hahm KB
    Biochem Pharmacol; 2020 Dec; 182():114290. PubMed ID: 33075311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of a proton pump inhibitor on bone metabolism in ovariectomized rats.
    Joo MK; Park JJ; Lee BJ; Kim JH; Yeon JE; Kim JS; Byun KS; Bak YT
    Mol Med Rep; 2013 Apr; 7(4):1267-72. PubMed ID: 23426758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro and in vivo protection against indomethacin-induced small intestinal injury by proton pump inhibitors, acid pump antagonists, or indomethacin-phosphatidylcholine.
    Lim YJ; Phan TM; Dial EJ; Graham DY; Lichtenberger LM
    Digestion; 2012; 86(2):171-7. PubMed ID: 22907267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proton pump inhibitors have no measurable effect on calcium and bone metabolism in healthy young males: a prospective matched controlled study.
    Sharara AI; El-Halabi MM; Ghaith OA; Habib RH; Mansour NM; Malli A; El Hajj-Fuleihan G
    Metabolism; 2013 Apr; 62(4):518-26. PubMed ID: 23102518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The potential inhibitory effect of revaprazan, an acid pump antagonist, on anticoagulation with warfarin.
    Jung JW; Kang HR; Kwon JW; Kim TE; Lee SH; Hong KS; Yu KS; Cho SH
    Tohoku J Exp Med; 2011 Aug; 224(4):293-300. PubMed ID: 21799301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-Term Proton Pump Inhibitor Use Is Not Associated With Changes in Bone Strength and Structure.
    Targownik LE; Goertzen AL; Luo Y; Leslie WD
    Am J Gastroenterol; 2017 Jan; 112(1):95-101. PubMed ID: 27845341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunocytochemical localization of vacuolar H+-ATPase and Cl--HCO3- anion exchanger (erythrocyte band-3 protein) in avian osteoclasts: effect of calcium-deficient diet on polar expression of the H+-ATPase pump.
    Bastani B; Ross FP; Kopito RR; Gluck SL
    Calcif Tissue Int; 1996 May; 58(5):332-6. PubMed ID: 8661962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A vacuolar ATPase inhibitor, FR167356, prevents bone resorption in ovariectomized rats with high potency and specificity: potential for clinical application.
    Niikura K; Takeshita N; Takano M
    J Bone Miner Res; 2005 Sep; 20(9):1579-88. PubMed ID: 16059630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A dairy product fermented by lactobacilli cancels the adverse effects of hypochlorhydria induced by a proton pump inhibitor on bone metabolism in growing rats.
    Takasugi S; Ashida K; Maruyama S; Komaba Y; Kaneko T; Yamaji T
    Br J Nutr; 2011 Nov; 106(10):1487-94. PubMed ID: 21736787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proton pump inhibitors use and change in bone mineral density.
    Arj A; Razavi Zade M; Yavari M; Akbari H; Zamani B; Asemi Z
    Int J Rheum Dis; 2016 Sep; 19(9):864-8. PubMed ID: 27242025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of Proton Pump Inhibitor Administration and Intake of a Combination of Yogurt and Galactooligosaccharides on Bone and Mineral Metabolism in Rats.
    Takasugi S; Shioyama M; Kitade M; Nagata M; Yamaji T
    Nutrients; 2016 Oct; 8(10):. PubMed ID: 27775655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of the selective oestrogen receptor modulator (raloxifene hydrochloride) on IL-6, TNF-alpha, TGF-beta1 and bone turnover markers in the treatment of postmenopausal osteoporosis.
    Ozmen B; Kirmaz C; Aydin K; Kafesciler SO; Guclu F; Hekimsoy Z
    Eur Cytokine Netw; 2007 Sep; 18(3):148-53. PubMed ID: 17823083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Revealing the Mechanistic Pathway of Acid Activation of Proton Pump Inhibitors To Inhibit the Gastric Proton Pump: A DFT Study.
    Jana K; Bandyopadhyay T; Ganguly B
    J Phys Chem B; 2016 Dec; 120(51):13031-13038. PubMed ID: 27992223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nissen fundoplication
    Zhang C; Hu ZW; Yan C; Wu Q; Wu JM; Du X; Liu DG; Luo T; Li F; Wang ZG
    World J Gastroenterol; 2017 May; 23(19):3546-3555. PubMed ID: 28596691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potassium-competitive acid blockers: Advanced therapeutic option for acid-related diseases.
    Inatomi N; Matsukawa J; Sakurai Y; Otake K
    Pharmacol Ther; 2016 Dec; 168():12-22. PubMed ID: 27514776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Supplementation with oral vitamin D3 and calcium during winter prevents seasonal bone loss: a randomized controlled open-label prospective trial.
    Meier C; Woitge HW; Witte K; Lemmer B; Seibel MJ
    J Bone Miner Res; 2004 Aug; 19(8):1221-30. PubMed ID: 15231008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Total and free deoxypyridinoline after acute osteoclast activity inhibition.
    Rubinacci A; Melzi R; Zampino M; Soldarini A; Villa I
    Clin Chem; 1999 Sep; 45(9):1510-6. PubMed ID: 10471654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proton pump inhibitors and hypomagnesemia in the general population: a population-based cohort study.
    Kieboom BC; Kiefte-de Jong JC; Eijgelsheim M; Franco OH; Kuipers EJ; Hofman A; Zietse R; Stricker BH; Hoorn EJ
    Am J Kidney Dis; 2015 Nov; 66(5):775-82. PubMed ID: 26123862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.